Novel small molecule therapeutics in rheumatoid arthritis.


A new wave of emerging therapies for the treatment of autoimmune and inflammatory diseases is under development. These therapies interrupt intracellular signalling through kinase inhibition. By interrupting one or more kinases it is possible to modulate the function of cellular structures such as surface receptors, signalling proteins and transcription of… (More)
DOI: 10.1093/rheumatology/kes367


4 Figures and Tables

Slides referencing similar topics